Medical Device
Manufacturer

医疗美容·Hyaluronic acid

GANA HA

Monophasic cross-linked hyaluronic acid with a 10 % cross-linking ratio and small, uniform particles: three filler types for different injection depths, plus a Booster type for mesotherapy.

01 概览

Hyaluronic acid dermal filler — Types A, B, C and Booster

  • 规格1.2 ml prefilled syringe × 1 per box (Types A, B and C); Booster type 2.5 ml
  • 成分
    • Cross-linked hyaluronic acid (BDDE cross-linked), no non-cross-linked HA added
    • HA concentration: Type A 24 mg/cc · Type B 22 mg/cc · Type C 20 mg/cc · Booster 6 mg/cc
    • Cross-linking ratio 10 % (Booster 5 %)
  • 成分类别Hyaluronic acid
  • 注册3 项有效 · 韩国 · 俄罗斯
  • 产品目录2026 年 GANA R&D 产品目录，第 10–11 页

产品详情以 GANA R&D 产品目录发布的英文版显示。

索取产品资料
GANA HA — Type A, B and C cartons with a 1.2 ml prefilled syringe

02 有据可查

本产品的注册信息

每一项注册均以 GANA R&D 为制造商，所有编号均可在主管机构的公开登记系统中核查。

注册名称司法管辖区注册授予日期范围核查
GANA HA — Umbrella licence covering ART AQUA and 21 further products 韩国 · MFDS 제허15-1662 2015年12月10日 出口 公开登记→
GANA HA TYPE 韩国 · MFDS 제허23-128 2023年2月24日 出口 公开登记→
GANA HA (A/B/C) 俄罗斯 · Roszdravnadzor РЗН 2021/14277 2021年5月7日 — 公开登记→

俄罗斯 Roszdravnadzor 登记系统使用俄罗斯国家颁发的证书，俄罗斯境外的浏览器在打开记录前可能会显示安全警告。

制造商

  • MFDS 制造业许可GANA R&D Co., Ltd. · MFDS No. 4490 · 公开登记→
  • GMP 证书KCL-ABBA-19926 · 有效期至 2027年3月3日
  • 生产场所555 Dunchon-daero, Jungwon-gu, Seongnam-si 13215, Republic of Korea

03 摘自产品目录

产品详情

转载自 2026 年 GANA R&D 产品目录。仅供医疗专业人员参考；本说明不能替代随产品提供的使用说明书。

Characteristics of GANA HA

  1. No addition of non-cross-linked HA
  2. Highest cross-linking ratio
  3. Highest HA concentration
  4. Small particle size, so the shape is easy to mould
  5. Higher viscosity than other dermal fillers
  6. Longest duration
  7. Low extrusion force
Biphasic and monophasic HA fillers
Biphasic HA fillersMonophasic HA fillers
Non-cross-linked HAAdded — disappears in 1–2 weeksNot added
Particle sizeLarge—
DurationRelatively shortLonger
Cross-linking ratioLowRelatively high
ShapingEasy to mouldDifficult to mould

GANA HA compared with existing fillers

MonophasicBiphasicGANA HA
Cross-linking ratio6–8 %2–4 %10 %
HA concentration (mg/cc)20–2420–2420–24
Cross-linking agentBDDEBDDEBDDE
Duration (months)6–126–1812–18
Particle sizeNone100–2000 µm50–100 µm
Viscosity (cPs)2–4 × 10⁶1–4 × 10⁶4–7 × 10⁶

Types and recommended use

TypeVolumeInjection layerNeedleHA (mg/cc)Cross-linkingRecommended use
Type A1.2 mlSubcutaneous25 G2410 %Large-volume augmentation
Type B1.2 mlDeep dermis27 G2210 %Moderate wrinkles
Type C1.2 mlDermis30 G2010 %Fine wrinkles
Booster2.5 mlEpidermis30 G65 %Mesotherapy
  • Forehead — Type A, Booster type
  • Around the eyes — Type C, Booster type
  • Nose — Type A, Booster type
  • Nasolabial fold — Type B, Booster type
  • Lips — Type B
  • Chin — Type A, Booster type

Specification

Test itemStandardResult
AppearanceColourless, transparent; no visible foreign matter, no air bubblesQualified
Hyaluronate content24 / 22 / 20 mg/mlQualified
pH6.5–7.6Qualified
Osmotic pressure (mOsmol/L)0.9–1.1Qualified
Particle size distributionType A: 1 mm, 23 G · Type B: 200–500 µm, 27 G · Type C: 50–100 µm, 30 G · Booster: under 30 µmQualified
Cross-linking agent (BDDE) residue≤ 2.0 µg/gQualified
Protein≤ 1.0 %Qualified
Heavy metals≤ 20 ppmQualified
Bacteria testNo bacterial growthQualified
Bacterial endotoxin test≤ 0.5 EU/mLQualified
Viscosity4–6 × 10⁶ cPsQualified
HaemolysisNo haemolysis ringQualified

The products were tested in conformity with the GANA R&D standard.

推荐剂量

  • Nose: 1–2 ml
  • Nasolabial fold: 2–3 ml
  • Forehead: 3–5 ml
  • Lips: over 1 ml each side
  • Cheek: 4–10 ml
  • Short chin: 2–4 ml
  • Sunken eye: 1 ml
  • Temporal depression: over 2 ml each side

04 产品组合

GANA R&D 的其他真皮填充剂

全部真皮填充剂→

索取技术资料。

本产品的注册证书、使用说明书和技术文件可应经销商和诊所的要求提供。

索取产品资料